Helping to share the web since 1996
Elsilimomab (also known as B-E8) is a mouse monoclonal antibody and an immunosuppressive drug. It (OPR-003) targets (and blocks) Interleukin-6. It has undergone a number of early stage clinical trails, e.g. for lymphoma and myeloma.
There are no posts for this page yet.
Upgrade Options